#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Head and neck cancer Ehlers-Danlos syndrome Acute hepatic failure Familial dilated cardiomyopathy Peritoneal neoplasm Hepatobiliary cancer Transitional cell carcinoma Acute myeloid leukaemia Prader-Willi syndrome Biliary neoplasm Alport's syndrome Pulmonary hypertension Dedifferentiated liposarcoma Diffuse large B-cell lymphoma Idiopathic inflammatory myopathy More trials…

    Learn about Rare Diseases

    Lymphangioma – Treatment Pemphigoid – Diagnostics Castleman’s disease – Life with Disease Tuberous sclerosis complex Haemophagocytic lymphohistiocytosis Brain stem glioma – Diagnostics Anaplastic thyroid cancer – Basic Information Haemolytic uraemic syndrome – Diagnostics CADASIL – Trials in Disease Toxic epidermal necrolysis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dronedarone Dnth103 N-Acetylhistidine Abc-15Bo-116 Emicizumab Nms-03592088 Pozelimab Bisoprolol Other Immunosuppressants Caffeine Citrate Abc-23B-116 Bi 690517 Sevoflurane GS-248 Cabazitaxel GSK5764227 OMTX705 Englumafusp Alfa Maralixibat Chloride LY3537031 More therapies…

    Learn about Your Condition

    Fontan procedure Hysterectomy Infertility male Incisional hernia Partial lipodystrophy Small cell carcinoma Oesophageal adenocarcinoma Spinal osteoarthritis Glomerulonephritis acute Cardiogenic shock Hydrocephalus Oral neoplasm Insomnia Primary hyperoxaluria Juvenile idiopathic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peripheral arterial occlusive disease

  • Triple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Hypercholesterolaemia
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Rosuvastatin
    • Bempedoic Acid
    • Ezetimibe
    Austria Germany

  • A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral artery angioplasty
    • Peripheral artery thrombosis
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Clopidogrel
    France

  • A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

    Recruiting

    3 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    France The Netherlands Poland Slovakia

  • Study of APAC (antiplatelet, anticoagulant) treatment in patients with peripheral arterial disease and chronic limb-threatening ischemia during blood vessel restoration procedure

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Heparin Sodium
    • Sodium Chloride
    • UNFRACTIONATED HEPARIN, PORCINE, CONJUGATED WITH HUMAN SERUM ALBUMIN
    Finland

  • Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • ALLOGENEIC REGULATORY MACROPHAGES
    Germany

  • Study on the Safety of Leukocyte-Platelet Rich Fibrin for Patients with Critical Limb Ischemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • FIBRIN
    Poland
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!